COVID-19: a vaccine for military use approved in China
Ad5-nCoV is one of eight Chinese vaccine candidates approved for human trials at home and abroad for respiratory disease caused by the new coronavirus.
Ad5-nCoV is one of eight Chinese vaccine candidates approved for human trials at home and abroad for respiratory disease caused by the new coronavirus.
So many enthusiastic engineers who want to help out are volunteering their expertise to develop a low-cost ventilator that any manufacturing facility could adapt to build
An engineers of TUOAA has designed a CPAP (Continuous Positive Airway Pressure) device that could help the 19 patients breathe more easily.
A strong focus on SDGs can be the signal to tackle the pandemic with technology impact investments.
It will work thanks to an AI algorithm that will integrate diagnostic images, clinical and laboratory parameters, inflammatory status, and genetic profile of the patient and the virus.
It is now clear that to protect us from Covid-19 infection it is important to pay attention to small everyday gestures. Always wear a mask and gloves. Since it is ...
A new study shows how cannabidiol could reduce the activity of key proteins used by the new coronavirus to enter in human cells The medical marijuana research strand has developed ...
The great news comes from a Chinese study that confirms the presence of specific antibodies against the new coronavirus weeks after the appearance of symptoms A bright light of hope ...
A mobile robot for the disinfection of environments, capable of sterilizing even outdoor non-healthy environments. This is the project of Robotica REstart, which aims to realize these robots and test ...
Working in total safety: this is the goal of the technological solutions that companies are developing to return to normality The coronavirus epidemic, in addition to a very serious public ...
The Patent ® Newspaper registered at the court of Salerno with n.42019. Editor-in-Chief Giovanni Sapere | Copyright 2019 © Creatiwa Studio S.r.l. Publisher | All rights reserved | For advertising: Creatiwa Studio Sr.l. Head office Via privata del Gonfalone 3, 20123 Milan | Registered office: Via Scavate Casse Rosse snc – 84131 Salerno | Tax code, VAT no. 05675660657 Registration with the Register of Companies of Salerno REA SA – 465001
2017 – 2025 The Patent ™ Director Giovanni Sapere
The Patent ® Newspaper registered at the court of Salerno with n.42019. Editor-in-Chief Giovanni Sapere | Copyright 2019 © Creatiwa Studio S.r.l. Publisher | All rights reserved | For advertising: Creatiwa Studio Sr.l. Head office Via privata del Gonfalone 3, 20123 Milan | Registered office: Via Scavate Casse Rosse snc – 84131 Salerno | Tax code, VAT no. 05675660657 Registration with the Register of Companies of Salerno REA SA – 465001